Considering that OCTN1 is expressed in dermal fibroblasts, both healthy- and systemic sclerosis-derived, a therapeutic role in systemic sclerosis has been hypothesized for this transporter. The gene discussed is SLC22A4; the disease is systemic sclerosis.